FDA Inspection 1062008 — Nina Bhardwaj, MD, PhD
The FDA completed an inspection of Nina Bhardwaj, MD, PhD on Jul 18, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 18, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Sponsor-Investigator (S-I)